Equitable Holdings’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Sell
42,876
-250
-0.6% -$7.32K 0.01% 898
2025
Q4
$1.25M Buy
43,126
+26,580
+161% +$798K 0.01% 787
2025
Q3
$459K Buy
+16,546
New +$418K ﹤0.01% 1111
2023
Q4
Sell
-7,227
Closed -$201K 1134
2023
Q3
$201K Buy
7,227
+573
+9% +$18.7K ﹤0.01% 1008
2023
Q2
$227K Buy
+6,654
New +$209K ﹤0.01% 950
2022
Q4
Sell
-12,250
Closed -$403K 900
2022
Q3
$403K Sell
12,250
-1,756
-13% -$64.5K 0.01% 614
2022
Q2
$441K Buy
14,006
+3,280
+31% +$115K 0.01% 588
2022
Q1
$493K Sell
10,726
-2,758
-20% -$131K 0.01% 578
2021
Q4
$826K Sell
13,484
-3,942
-23% -$273K 0.01% 442
2021
Q3
$1.3M Buy
17,426
+2,181
+14% +$183K 0.02% 329
2021
Q2
$1.41M Buy
15,245
+981
+7% +$83.4K 0.02% 311
2021
Q1
$1.27M Buy
14,264
+2,324
+19% +$231K 0.03% 316
2020
Q4
$1.11M Sell
11,940
-280
-2% -$22.3K 0.03% 304
2020
Q3
$779K Buy
12,220
+6,649
+119% +$390K 0.02% 337
2020
Q2
$291K Buy
+5,571
New +$239K 0.01% 511

Other funds holding ARKG

Equitable Holdings's ARKG Position: Q1 2026 in Review

Equitable Holdings reduced its ARK Genomic Revolution ETF (ARKG) stake by 0.58% in Q1 2026, selling an estimated $7.32K and leaving 42,876 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #898.

Equitable Holdings first reported a position in ARKG in Q2 2020 and has held it in 15 quarters since. The position peaked at $1.41M in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Equitable Holdings held 42,876 shares of ARK Genomic Revolution ETF worth $1.24M as of Q1 2026.
  • Equitable Holdings sold 250 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $7.32K.
  • ARK Genomic Revolution ETF made up 0.01% of Equitable Holdings's portfolio in Q1 2026, its #898 holding.
  • Equitable Holdings first reported a position in ARK Genomic Revolution ETF in Q2 2020 and has held it in 15 quarters since.
  • Equitable Holdings's ARK Genomic Revolution ETF position peaked at $1.41M in Q2 2021.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.